Kiromic BioPharma, Inc. (KRBP)
OTCMKTS · Delayed Price · Currency is USD
1.615
-0.315 (-16.32%)
Feb 20, 2025, 3:00 PM EST

Kiromic BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Feb '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
21132462
Upgrade
Market Cap Growth
27.08%27.08%-66.79%-86.04%-61.97%-
Upgrade
Enterprise Value
1613852173
Upgrade
Last Close Price
1.610.900.875.4245.90254.10
Upgrade
PB Ratio
-0.11-0.11-0.12-0.570.865.47
Upgrade
P/TBV Ratio
----0.865.47
Upgrade
Debt / Equity Ratio
-1.16-1.16-1.70-1.630.020.04
Upgrade
Quick Ratio
0.050.050.160.057.446.92
Upgrade
Current Ratio
0.160.160.220.137.947.32
Upgrade
Return on Equity (ROE)
----322.40%-132.30%-287.84%
Upgrade
Return on Assets (ROA)
-143.47%-143.47%-103.26%-91.09%-72.62%-79.21%
Upgrade
Return on Capital (ROIC)
-353.65%-353.65%-247.81%-123.82%-79.87%-88.81%
Upgrade
Earnings Yield
-186.82%-1933.26%-1913.40%-1053.35%-108.34%-30.91%
Upgrade
FCF Yield
-800.57%-1424.83%-1957.51%-868.21%-94.06%-12.21%
Upgrade
Buyback Yield / Dilution
-33.09%-33.09%-101.59%-43.07%-153.38%-57.39%
Upgrade
Total Shareholder Return
-33.09%-33.09%-101.59%-43.07%-153.38%-57.39%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.